MOUNTAIN VIEW, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Locus Technologies, the sustainability and Environmental Health and Safety (EHS) compliance software leader, announced the release of Locus ...
RESEARCH TRIANGLE PARK, N.C., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Locus Biosciences, Inc. (“Locus”), a clinical-stage biotechnology company developing a new class of precision engineered bacteriophage ...
TAIPEI, Sept. 29, 2025 /PRNewswire/ -- Locus Cell (TWSE: 6891), a leading regenerative medicine CDMO in Taiwan, announced it has signed a Memorandum of Understanding (MOU) with Australia-based Cambium ...
Locus Biosciences (Locus) has begun treating the first patient in its phase 2/3 trial of LBP-EC01, in partnership with the Biomedical Advanced Research and Development Authority (BARDA), for the ...
Recent funding round, led by Hudson Bay Capital, fuels expanded capacity and commercialization of formulated intermediates across oil & gas, mining, agriculture and industrial & CPG markets SOLON, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback